Company Cash Funds: alkermes.com (ALKS)

Graphic logo of Alkermes (ALKS)

Alkermes plc (ALKS) is implementing advanced drug delivery methods for the therapy of brain pathologies. On GURU.Markets, the cash position demonstrates the business's liquidity, with the value recorded at 0.76. Stability is ensured by its Irish status and the protection of supply chains. Market capitalization growth is supported by the success of Lybalvi and Aristada, as well as strategic share buybacks and a focus on neuropsychiatry.

Company Cash on Hand: Alkermes PLC (ALKS) for 07/04/2022 - 11/21/2026

Analytical breakdowns and data insights for company Alkermes Inc. (ALKS)

- stock quotes and analyst forecast:
- company stock exchange capitalization indicators:
Fundamental valuation:ALKS Alkermes Inc.
Signature product of Alkermes PLC

This indicator captures the volume of liquid assets on the balance sheet, allowing for an assessment of financial stability and the rate of capital expenditure projected for future periods. By analyzing the level of cash capital, an investor can determine the ability of Alkermes plc (ALKS) to fund strategic alliances and M&A transactions within the mental health sector without resorting to costly external borrowing.